NL7512590A - Isolation of high purity thermolabile E. coli enterotoxin - from culture filtrates by isotachophoresis or affinity chromatography (BE300476) - Google Patents

Isolation of high purity thermolabile E. coli enterotoxin - from culture filtrates by isotachophoresis or affinity chromatography (BE300476)

Info

Publication number
NL7512590A
NL7512590A NL7512590A NL7512590A NL7512590A NL 7512590 A NL7512590 A NL 7512590A NL 7512590 A NL7512590 A NL 7512590A NL 7512590 A NL7512590 A NL 7512590A NL 7512590 A NL7512590 A NL 7512590A
Authority
NL
Netherlands
Prior art keywords
thermolabile
high purity
isotachophoresis
isolation
enterotoxin
Prior art date
Application number
NL7512590A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1467174A external-priority patent/CH612994A5/de
Priority claimed from CH604075A external-priority patent/CH615196A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL7512590A publication Critical patent/NL7512590A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL7512590A 1974-11-01 1975-10-28 Isolation of high purity thermolabile E. coli enterotoxin - from culture filtrates by isotachophoresis or affinity chromatography (BE300476) NL7512590A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1467174A CH612994A5 (en) 1974-11-01 1974-11-01 Process for the preparation of coli enterotoxin
CH1645874 1974-12-11
CH1645974 1974-12-11
CH604075A CH615196A5 (en) 1975-05-12 1975-05-12 Purification process for coli enterotoxin

Publications (1)

Publication Number Publication Date
NL7512590A true NL7512590A (en) 1976-05-04

Family

ID=27428963

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7512590A NL7512590A (en) 1974-11-01 1975-10-28 Isolation of high purity thermolabile E. coli enterotoxin - from culture filtrates by isotachophoresis or affinity chromatography (BE300476)

Country Status (16)

Country Link
JP (1) JPS5170810A (US06265458-20010724-C00033.png)
AU (1) AU511934B2 (US06265458-20010724-C00033.png)
CA (1) CA1053152A (US06265458-20010724-C00033.png)
DD (1) DD124879A5 (US06265458-20010724-C00033.png)
DE (1) DE2547224A1 (US06265458-20010724-C00033.png)
DK (2) DK478575A (US06265458-20010724-C00033.png)
ES (1) ES442242A1 (US06265458-20010724-C00033.png)
FI (2) FI752964A (US06265458-20010724-C00033.png)
FR (1) FR2289206A1 (US06265458-20010724-C00033.png)
GB (1) GB1529871A (US06265458-20010724-C00033.png)
IE (1) IE43702B1 (US06265458-20010724-C00033.png)
IL (1) IL48384A (US06265458-20010724-C00033.png)
NL (1) NL7512590A (US06265458-20010724-C00033.png)
NO (1) NO753578L (US06265458-20010724-C00033.png)
NZ (1) NZ179108A (US06265458-20010724-C00033.png)
SE (1) SE8100404L (US06265458-20010724-C00033.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738364B (en) * 1972-12-04 1974-09-25 Rit Rech Ind Therapeut Piglet colibacillosis vaccines and process for their preparation

Also Published As

Publication number Publication date
AU511934B2 (en) 1980-09-11
DE2547224A1 (de) 1976-05-13
SE8100404L (sv) 1981-01-23
DK478575A (da) 1976-05-02
FI782827A (fi) 1978-09-14
NZ179108A (en) 1978-07-28
IE43702L (en) 1976-05-01
FR2289206A1 (fr) 1976-05-28
DD124879A5 (US06265458-20010724-C00033.png) 1977-03-16
IE43702B1 (en) 1981-05-06
IL48384A (en) 1979-05-31
NO753578L (US06265458-20010724-C00033.png) 1976-05-04
DK278478A (da) 1978-06-20
FI752964A (US06265458-20010724-C00033.png) 1976-05-02
FR2289206B1 (US06265458-20010724-C00033.png) 1978-11-10
JPS5170810A (US06265458-20010724-C00033.png) 1976-06-18
AU8628275A (en) 1977-05-12
GB1529871A (en) 1978-10-25
ES442242A1 (es) 1977-08-01
IL48384A0 (en) 1976-03-31
CA1053152A (en) 1979-04-24

Similar Documents

Publication Publication Date Title
FR2389400B1 (US06265458-20010724-C00033.png)
NL7512590A (en) Isolation of high purity thermolabile E. coli enterotoxin - from culture filtrates by isotachophoresis or affinity chromatography (BE300476)
ES404095A1 (es) Un procedimiento para la recuperacion de oxido de etileno.
CA958904A (en) Gas turbine regenerator assembly and assembly method
AU568743B2 (en) Pertussis vaccine
CA978117A (en) Method of producing maltose of high purity
CA967440A (en) Method for the operation of internal-combustion engines and gas reformer for implementing the method
GB1401588A (en) Vaccine and method for its production
JPS5217404A (en) Process for separation of butanediol
JPS5228870A (en) Method for production of thin membrane
JPS5247978A (en) Method of converting methnol to protein rich mycelium by microorganism
ES262654A1 (es) Un metodo para hacer preparaciones inmunizantes
AU471488B1 (en) Process and apparatus for gas purification and recovering useful byproduct
FR2314921A1 (fr) Procede de pyrolyse du borohydrure de tetraethylammonium
GB912353A (en) Improvements in processes for the production of 1-glutamic acid
CA962038A (en) Method of effecting reaction between liquid and gas
JPS52144900A (en) Lapping method
GR21208B (el) Μεθοδος παρασκευης ακετυλο - σαλικιλικου οξεος.
GB863408A (en) Method of producing chlorofluoro-derivatives of aliphatic hydrocarbons
CA860375A (en) Fuel nozzles for high temperature furnace, and method of operating
GB1396754A (en) Process for preparing alpha-keto esters
CA871622A (en) Method of heating co-containing gases
CA840195A (en) Split pressure low temperature process for the production of gases of moderate purity
CA875685A (en) Method and apparatus for heating gases to high temperatures
CA871623A (en) Method of producing reducing gas

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed